Clinical Mass Spectrometry

Clinical Mass Spectrometry,ISSN 2376-9998,eISSN 2213-8005 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2025 年数据 · 影响因子
-
JCR 分区
-
CAS 分区
-
近一年发文量
0

指标来源:fiveyear

ISSN: 2376-9998 · eISSN: 2213-8005 · 缩写: -

期刊简介

暂无简介。

历年影响因子趋势

年份影响因子JCR 分区
-Q3
-Q3
-Q3

Clinical Mass Spectrometry 最新收录文献

  1. Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phthalates and bisphenol a in serum, urine and follicular fluid.

    Phthalates and bisphenol A interfere with the synthesis, secretion, transport, binding, metabolism, and excretion of endogenous hormones and, for this reason, are classified as endocrine disruptors. W…

    查看详情 DOI
  2. Collision energy-breakdown curves - An additional tool to characterize MS/MS methods.

    In tandem mass spectrometry, analyte detection is based on collision-induced fragmentation, which is modulated by the collision energy (CE) setting. Variation in CE leads to differential ion yield, an…

    查看详情 DOI
  3. Analysis of 17 fentanyls in plasma and blood by UPLC-MS/MS with interpretation of findings in surgical and postmortem casework.

    The opioid crisis is linked to an increased misuse of fentanyl as well as fentanyl analogs that originate from the illicit drug market. Much of our current understanding of fentanyl and fentanyl analo…

    查看详情 DOI
  4. Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review.

    The development of non-invasive screening techniques for early cancer detection is one of the greatest scientific challenges of the 21st century. One promising emerging method is the analysis of volat…

    查看详情 DOI
  5. A proposal for score assignment to characterize biological processes from mass spectral analysis of serum.

    Most diseases involve a complex interplay between multiple biological processes at the cellular, tissue, organ, and systemic levels. Clinical tests and biomarkers based on the measurement of a single …

    查看详情 DOI
  6. Mass spectrometry in clinical glycomics: The path from biomarker identification to clinical implementation.

    Over the past decades, the genome and proteome have been widely explored for biomarker discovery and personalized medicine. However, there is still a large need for improved diagnostics and stratifica…

    查看详情 DOI
  7. {"_":"Direct detection of intact carbapenemase variants from cell lysates: Identification, characterization and clinical implications.","i":["Klebsiella pneumoniae"]}

    Carbapenemase-producing organisms (CPOs) are a growing threat to human health. Among the enzymes conferring antibiotic resistance produced by these organisms, carbapenemase (KPC) is considered to be a…

    查看详情 DOI
  8. Averaging of results derived from different, simultaneously acquired mass transitions in ID-LC-MS/MS - Potential impact on measurement imprecision.

    LC-MS/MS allows for many measurands monitoring different mass transitions simultaneously. So far, such alternative mass transitions are usually assessed as "quantifier and qualifier ions" in order to …

    查看详情 DOI
  9. {"_":"Determination of methicillin-resistant and by MALDI-TOF MS in clinical isolates from Latvia.","i":["Staphylococcus aureus","Staphylococcus epidermidis"]}

    Rapid identification of methicillin-resistant could ensure appropriate medical care. A total of 409 spp. strains were used to develop a reliable MALDI-TOF method for species identification. We tested …

    查看详情 DOI
  10. A suggested standard for validation of LC-MS/MS based analytical series in diagnostic laboratories.

    •Policies applied to confirm LC-MS/MS-based results differ between laboratories.•We suggest a systematic approach for validation of individual diagnostic series.•An individual series validation plan c…

    查看详情 DOI

在 Clinical Mass Spectrometry 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读